MVP 2.44% 40.0¢ medical developments international limited

Pre-conditions for marketing approval in France have been met so...

  1. 351 Posts.
    lightbulb Created with Sketch. 1
    Pre-conditions for marketing approval in France have been met so it's the next announcement I am expecting. That's a $US 3M milestone payment. Hopefully, we will see the forecast order numbers for France and Belgium when the announcement is made.

    I am using a popular share analyser (PSA) and as at 28th of August 2015, PSA put a share price valuation of 85 cents on MVP. Currently, the valuation is $6.32. The valuation takes into account milestone payments and forecasts. It's a blackbox number so I don't know exactly how it is calculated or the inputs taken up. Revenue as it is announced is taken up in the EPS metric and currently PSA calculates EPS to be 32cents and P/E to be 12.06. As at 28th of August EPS was 4 cents and P/E was 57.5.

    My only recommendation is.... to do your own research before making investment decisions.

    Cheers,

    Malco
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
-0.010(2.44%)
Mkt cap ! $34.52M
Open High Low Value Volume
40.0¢ 40.5¢ 40.0¢ $3.981K 9.899K

Buyers (Bids)

No. Vol. Price($)
6 62022 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
41.0¢ 815 2
View Market Depth
Last trade - 15.59pm 04/07/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.